Pharmacist Phone Calls May Improve LDL Cholesterol

How Can Pharmacist Phone Calls Help Lower LDL Cholesterol?

Cholesterol-lowering medicines such as statins, ezetimibe and PCSK9 inhibitors can substantially reduce cardiovascular risk when taken as prescribed, but real-world adherence is often lower than in clinical trials. The research highlighted by Medical Xpress suggests that structured pharmacist follow-up by phone may help patients stay on treatment, understand their LDL cholesterol targets and solve common problems such as missed doses, uncertainty about side effects or confusion about repeat prescriptions.

This matters because LDL cholesterol is a causal driver of atherosclerotic cardiovascular disease. Large meta-analyses from the Cholesterol Treatment Trialists' Collaboration have shown that lowering LDL cholesterol reduces major vascular events, particularly among people at elevated risk. A phone-based pharmacist intervention is not a new drug, but it may make existing evidence-based drugs work better in daily practice.

Why Is Medication Adherence So Important in Cholesterol Treatment?

Guidelines from the American College of Cardiology and American Heart Association emphasize LDL cholesterol reduction as a central goal in preventing heart attack and stroke. For many patients, especially those with previous cardiovascular disease, diabetes or very high baseline LDL cholesterol, long-term medication is needed alongside diet, physical activity, smoking cessation and blood pressure control.

Adherence problems can arise for many reasons: muscle symptoms, concerns about long-term safety, cost, complicated medication schedules or lack of follow-up after a prescription is started. Pharmacists are well placed to identify these barriers because they routinely review medication records, counsel patients and coordinate with prescribers. A brief phone call can also create a low-friction way to check whether a patient has started therapy, continued refills and understood why treatment matters.

Could Pharmacist-Led Cholesterol Care Change Cardiovascular Prevention?

Cardiovascular disease remains the world's leading cause of death, with WHO estimating about 17.9 million deaths each year. Because elevated LDL cholesterol is common and treatable, health systems are increasingly testing team-based models that extend care beyond the physician visit. Pharmacist-led medication management has already shown value in areas such as hypertension, anticoagulation and diabetes care.

The key question is whether phone-based follow-up produces lasting LDL cholesterol reductions and improves hard outcomes such as heart attacks, strokes and hospitalizations. Even without replacing clinic visits, pharmacist calls may be especially useful after a new statin prescription, a dose increase, or the addition of ezetimibe or a PCSK9-targeting therapy for patients who remain above goal.